RS52536B - Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mtor inhibitors - Google Patents

Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mtor inhibitors

Info

Publication number
RS52536B
RS52536B RS20120524A RSP20120524A RS52536B RS 52536 B RS52536 B RS 52536B RS 20120524 A RS20120524 A RS 20120524A RS P20120524 A RSP20120524 A RS P20120524A RS 52536 B RS52536 B RS 52536B
Authority
RS
Serbia
Prior art keywords
group
thiol
halo
carboxy
cyano
Prior art date
Application number
RS20120524A
Other languages
Serbian (sr)
Inventor
Keith Allan Menear
Marc Geoffrey Hummersone
Sylvie Gomez
Graeme Cameron Murray Smith
Karine Malagu
Heather Mary Ellen Duggan
Xiao-Ling Fan Cockcroft
Gesine Johanna Hermann
Original Assignee
Kudos Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kudos Pharmaceuticals Ltd filed Critical Kudos Pharmaceuticals Ltd
Priority claimed from PCT/GB2006/004327 external-priority patent/WO2007060404A1/en
Publication of RS52536B publication Critical patent/RS52536B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Jedinjenje sa formulom I:naznačeno time da:X8 je N, i X5 i X6 su CH;R7 je C5-20 arilna grupa po izboru supstituisana sa jednom ili više grupa izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, i tiol, ili C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino (svaka po izboru supstituisana sa jednom ili više izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, tiol, C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino);RN3 i RN4, zajedno sa azotom na kojeg su povezani, grade heterociklični prsten koji sadrži između 3 i 8 atoma u prstenu po izboru supstituisanih sa jednom ili više grupa izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, i tiol, ili C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino (svaka po izboru supstituisana sa jednom ili više izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, tiol, C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino);R2 je izabran iz NRN5RN6, C5-20 heteroarilne grupe po izboru supstituisane sa jednom ili više grupa izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, i tiol, ili C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino (svaka po izboru supstituisana sa jednom ili više izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, tiol, C1-7alkil, C2-7alkenil, C2-7alkinil, C3-7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino), te C5-20 arilne grupe po izboru supstituisane sa jednom ili više grupa izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, i tiol, ili C1-7alkil, C2-7alkenil, C2-7alkinil, C3- 7cikloalkil, C3-7cikloalkenil, C3-20heterociklil, C5-20aril, C5-20heteroaril, etar, acil, estar, amido, amino, acilamido, ureido, aciloksi, tioetar, sulfoksid, sulfonil, tioamido i sulfonamino (svaka po izboru supstituisana sa jednom ili više izabranih iz grupe koja sadrži halo, hidroksil, nitro, cijano, karboksi, tiol, C1-7aCompound of Formula I: wherein: X8 is N, and X5 and X6 are CH; R7 is a C5-20 aryl group optionally substituted by one or more groups selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy. and thiol, or C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy, thioether, sulfoxide, sulfonyl, thioamido and sulfonamino (each optionally substituted by one or more selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, thiol, C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3 -7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy, thioether, sulfoxide, sulfonyl, thioamido and sulfonamino); together with the nitrogen to which they are attached, form a heterocyclic ring containing between 3 and 8 ring atoms optionally substituted by one or more groups and selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, and thiol, or C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5- Heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy, thioether, sulfoxide, sulfonyl, thioamido and sulfonamino (each optionally substituted by one or more selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy , thiol, C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy , thioether, sulfoxide, sulfonyl, thioamido and sulfonamino); R2 is selected from NRN5RN6, C5-20 heteroaryl group optionally substituted by one or more groups selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, and thiol, or C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20 heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, aci l, ester, amido, amino, acylamido, ureido, acyloxy, thioether, sulfoxide, sulfonyl, thioamido and sulfonamino (each optionally substituted by one or more selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, thiol, C1 -7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy, thioether , sulfonyl, thioamido and sulfonamino), and C5-20 aryl groups optionally substituted by one or more groups selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, and thiol, or C1-7alkyl, C2-7alkenyl, C2 -7alkynyl, C3-7cycloalkyl, C3-7cycloalkenyl, C3-20heterocyclyl, C5-20aryl, C5-20heteroaryl, ether, acyl, ester, amido, amino, acylamido, ureido, acyloxy, thioether, sulfoxide, sulfonyl, thioamido and sulfonamide (each optionally substituted by one or more selected from the group consisting of halo, hydroxyl, nitro, cyano, carboxy, thiol, C1-7a

RS20120524A 2005-11-22 2006-11-20 Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mtor inhibitors RS52536B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73890205P 2005-11-22 2005-11-22
GB0524047A GB0524047D0 (en) 2005-11-25 2005-11-25 Compounds
US82330806P 2006-08-23 2006-08-23
US82330906P 2006-08-23 2006-08-23
PCT/GB2006/004327 WO2007060404A1 (en) 2005-11-22 2006-11-20 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS

Publications (1)

Publication Number Publication Date
RS52536B true RS52536B (en) 2013-04-30

Family

ID=35601230

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120524A RS52536B (en) 2005-11-22 2006-11-20 Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mtor inhibitors

Country Status (10)

Country Link
BR (1) BRPI0618874A2 (en)
DK (1) DK1954699T3 (en)
ES (1) ES2394470T3 (en)
GB (1) GB0524047D0 (en)
ME (1) ME01487B (en)
MY (1) MY153209A (en)
NZ (1) NZ567787A (en)
PT (1) PT1954699E (en)
RS (1) RS52536B (en)
SI (1) SI1954699T1 (en)

Also Published As

Publication number Publication date
MY153209A (en) 2015-01-29
BRPI0618874A2 (en) 2011-09-13
NZ567787A (en) 2011-07-29
SI1954699T1 (en) 2013-01-31
PT1954699E (en) 2012-12-11
DK1954699T3 (en) 2013-01-02
ME01487B (en) 2014-04-20
GB0524047D0 (en) 2006-01-04
ES2394470T3 (en) 2013-02-01

Similar Documents

Publication Publication Date Title
AR055071A1 (en) PIRROLO DERIVATIVES (3,2 - B) PYRIMIDINE. PHARMACEUTICAL COMPOSITIONS.
RS53019B (en) Adamantyl diamide derivatives and uses of same
ECSP12006640A (en) ASPARTIL PROTEASA HETEROCYCLIC INHIBITORS
RS52261B (en) Amidophenoxyindazoles useful as inhibitors of c-met
DK1755606T4 (en) Quinazolinone derivatives useful as vanilloid antagonists
UY29312A1 (en) PIPERAZIN-1-CARBOXAMIDAS N, 4, SUBSTITUTES AND THEIR DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
DK1485365T3 (en) Sulfonyl derivatives as novel inhibitors of histane deacetylase
DK2091948T3 (en) Novel inhibitors of glutaminyl cyclase
CR9234A (en) DERIVATIVES OF 2,4 (4,6) PYRIMIDINE
NI200700056A (en) NEW DERIVATIVES OF SULFAMIDS OF HETEROARIL BENZO-FUNDIDO USEFUL AS ANTI-CONVERSION AGENTS
RS53392B (en) Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
AR048641A1 (en) ARTH- OR HETEROARILAMIDE ORTHOSUSTITUTED COMPOUNDS USEFUL AS ANTAGO-NISTAS OF THE PROSTAGLANDINAS E2 RECEIVER; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICAME
UY28764A1 (en) POLYHETHEROCYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
AR064197A1 (en) PIRIMIDINE AND PYRIDINE DERIVATIVES INHIBITORS OF PROTEIN QUINASA
DK1981871T3 (en) Heterocyclyl alkyl derivatives as novel inhibitors of histone deacetylase
MEP22308A (en) Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
UY30748A1 (en) NEW COMPOUNDS
NO20044063L (en) Pyranones useful as ATM inhibitors
RS51193B (en) Hydantoin derivatives useful as metalloproteinase inhibitors
ECSP066304A (en) COMPOUNDS
RS51226B (en) Azapeptide derivatives as hiv protease inhibitors
DE602007010458D1 (en) REVERSIBLE THERMOCHROME COMPOSITIONS
RS52515B (en) Fast dissociating dopamine 2 receptor antagonists
NI201000134A (en) NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.